Response to comment document

Response to Comments 60-day.docx

Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biological and Supporting Regulations (CMS-10110)

Response to comment document

OMB: 0938-0921

Document [docx]
Download: docx | pdf

CMS Response to Public Comments Received for CMS-10110



The Centers for Medicare and Medicaid Services (CMS) received comments from Prime Healthcare and a hospital oncology group related to CMS-10110. This is the reconciliation of the comments.



Comment:


The Centers for Medicare and Medicaid Services (CMS) received comments from Prime Healthcare that described the ASP pricing for reimbursement determination as “not fair for providers” and further stated that ASP pricing needs across-the-board upward adjustment because ASP is less than actual drug costs.


Response:


We acknowledge the comment regarding ASP pricing, although since said comment is out of scope regarding this collection, no changes will be made to the collection


Comment:


The Centers for Medicare and Medicaid Services (CMS) received comments from Prime Healthcare that described the ASP pricing for reimbursement determination as “not fair for providers” and further stated that ASP pricing needs across-the-board upward adjustment because ASP is less than actual drug costs. This commenter also stated that “Medicare is putting small businesses out of business, and prohibiting new small businesses from entering the healthcare industry, especially in critical access areas, rural areas, underserved and poor minority communities.


Response:


We acknowledge the comment regarding ASP pricing, although since said comment is out of scope regarding this collection, no changes will be made to the collection


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleCMS Response to Public Comments Received for CMS-10150
AuthorThomas E. Dudley
File Modified0000-00-00
File Created2023-08-02

© 2024 OMB.report | Privacy Policy